The global stool softener market size was USD 1.53 billion in 2021 and is expected to register a revenue CAGR of 7.15% during the forecast period, according to the latest analysis by Emergen Research. The increasing geriatric population suffering from constipation is a major factor driving market revenue growth.
The Global Stool Softener Market research report is a complete document that explains the most recent breakthroughs and advancements in the Stool Softener industry, using 2019 as the base year and 2022–2030 as the forecast year. The analysis offers insightful data on the market's size, share, sales channels, distribution networks, market segmentation, consumer demands and trends, and growth prospects. The expansion of regional and global markets is also examined in the study. In the paper, the effect of the COVID-19 pandemic on the market for Stool Softener and its important sectors is studied.
Stool softeners are used to alleviate pain and other physiological problems experienced by patients suffering from constipation, irritable bowel syndrome, opioid-induced constipation, and other conditions. According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), in the U.S., around 16 in 100 adults and 33 in 100 adults above the age of 60 suffer from constipation or have symptoms of this medical condition.
To receive a sample copy of this report, visit @ https://www.emergenresearch.com/request-sample/1094
The study outlines the rapidly evolving and growing market segments along with valuable insights into each element of the industry. The industry has witnessed the entry of several new players, and the report aims to deliver insightful information about their transition and growth in the market. Mergers, acquisitions, partnerships, agreements, product launches, and joint ventures are all outlined in the report.
The leading market contenders listed in the report are:
AstraZeneca plc, Starmed Pvt. Ltd., Rapkatos Brett Co., Ltd., Solvay S.A., GlaxoSmithKline plc., Amato Pharmaceutical Products, Ltd., Avrio Health, L.P., Bayer AG, Abbott Laboratories, Boehringer Ingelheim GmbH
Target Audience of the Global Stool Softener Market Report:
- Key Market Players
- Investors
- Venture capitalists
- Small- and medium-sized and large enterprises
- Third-party knowledge providers
- Value-Added Resellers (VARs)
- Global market producers, distributors, traders, and suppliers
- Research organizations, consulting companies, and various alliances interested in this sector
- Government bodies, independent regulatory authorities, and policymakers
Get a discount on the Global Stool Softener Market report @ https://www.emergenresearch.com/request-discount/1094
Major Geographies Analyzed in the Report:
- North America (U.S., Canada)
- Europe (U.K., Italy, Germany, France, Rest of EU)
- Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
- Latin America (Chile, Brazil, Argentina, Rest of Latin America)
- Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Market Segmentations of the Stool Softener Market
This market is segmented based on Types, Applications, and Regions. The growth of each segment provides accurate forecasts related to production and sales by Types and Applications, in terms of volume and value for the period between 2020 and 2028. This analysis can help readers looking to expand their business by targeting emerging and niche markets. Market share data is given on both global and regional levels. Regions covered in the report are North America, Europe, Asia Pacific, Latin America, and Middle East Africa. Research analysts assess the market positions of the leading competitors and provide competitive analysis for each company. For this study, this report segments the global Stool Softener market on the basis of product, application, and region:
Segments Covered in this report are:
- Form Outlook (Revenue, USD Billion; 2019-2030)
- Medicines
- Capsule
- Liquid
- Powder
- Procedures
- Enema
- Suppository
- Mode of Administration Outlook (Revenue, USD Billion; 2019-2030)
- Oral
- Rectal
- Availability Outlook (Revenue, USD Billion; 2019-2030)
- Over-the-Counter
- Prescription
Browse Full Report Description + Research Methodology + Table of Content + Infographics @ https://www.emergenresearch.com/industry-report/stool-softener-market
Some Key Highlights From the Report
- The home care segment accounted for a significant revenue share in the global stool softener market in 2021. Rising usage of stool softening medications and procedures by patients of constipation and other bowel-related syndromes in convenience of their homes is supporting revenue growth of this segment. Use of oral and rectal medications for stool softening by patients in their house allow patients to be relaxed before administration of medicine, which is especially important in case the treatment is a rectal procedure such as enema, or suppository. Patients are also able to maintain diets and exercise, along with reducing the medical cost, which is increasing preference for home care treatment and is expected to drive revenue growth in the coming years.
- The oral segment accounted for a significant revenue share in 2021. Increasing demand for oral stool softening medications is contributing to revenue growth of this segment. Oral drugs, capsules, powdered formulations, and liquids are easily available, easy to use, and are non-invasive, which has resulted in increasing preference of patients to adopt oral treatment methods for constipation over the years.
- The stool softener market in North America is expected to register a rapid revenue growth rate during the forecast period. Increasing incidences of pediatric constipation as well as other bowel-related medical conditions, along with presence of major companies in the market in countries in this region, is a key factor driving market revenue growth. Countries in this region have a number of approved-for-use softgels and other medications for softening of stool, which are available over-the-counter. Increasing patient preference to obtain self-treatment by purchasing OTC medicines is expected to drive revenue growth of the North America market between 2022 and 2030.
Additional information offered by the report:
- Along with a complete overview of the global Stool Softener market, the report provides detailed scrutiny of the diverse market trends observed on both regional and global levels.
- The report elaborates on the global Stool Softener market size and share governed by the major geographies.
- It performs a precise market growth forecast analysis, cost analysis, and a study of the micro- and macro-economic indicators.
- It further presents a detailed description of the company profiles of the key market contenders.
Request Customization as per your specific requirement@ https://www.emergenresearch.com/request-for-customization/1094
Thank you for reading our report. Customization of the report is available according to the requirements of our clients. Kindly get in touch with us to know more about the customization options, and our team will ensure the report is tailored according to your needs.
Latest Published Reports by Emergen Research:
interventional cardiology market
https://www.emergenresearch.com/industry-report/interventional-cardiology-market
small modular reactor market
https://www.emergenresearch.com/industry-report/small-modular-reactor-market
cell-free dna testing market
https://www.emergenresearch.com/industry-report/cell-free-dna-market
smart glass market
https://www.emergenresearch.com/industry-report/smart-glass-market
biometrics market
https://www.emergenresearch.com/industry-report/biometrics-market
diabetic care market
https://www.emergenresearch.com/industry-report/diabetic-care-market
human centric lighting market
https://www.emergenresearch.com/industry-report/human-centric-lighting-market
needle coke market
https://www.emergenresearch.com/industry-report/needle-coke-market
automated breast ultrasound market
https://www.emergenresearch.com/industry-report/automated-breast-ultrasound-market
direct-to-consumer genetic testing market
https://www.emergenresearch.com/industry-report/direct-to-consumer-genetic-testing-market
About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Latest Report: diabetic care market, autorefractor market
Trending Title: functional fibers market, vaccine market
